BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20225952)

  • 1. Challenges in implementing HIV load testing in South Africa.
    Stevens WS; Marshall TM
    J Infect Dis; 2010 Apr; 201 Suppl 1():S78-84. PubMed ID: 20225952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory operations, specimen processing, and handling for viral load testing and surveillance.
    Puren A; Gerlach JL; Weigl BH; Kelso DM; Domingo GJ
    J Infect Dis; 2010 Apr; 201 Suppl 1():S27-36. PubMed ID: 20225943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of human immunodeficiency virus type 1 viral load in plasma using reverse transcriptase activity assay at a district hospital laboratory in Botswana: a decentralization pilot study.
    Mine M; Bedi K; Maruta T; Madziva D; Tau M; Zana T; Gaolathe T; Moyo S; Seipone K; Ndwapi N; Essex M; Marlink R
    J Virol Methods; 2009 Jul; 159(1):93-7. PubMed ID: 19442851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma viral load testing in the management of HIV infection.
    Mylonakis E; Paliou M; Rich JD
    Am Fam Physician; 2001 Feb; 63(3):483-90, 495-6. PubMed ID: 11272298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring for treatment failure in patients on first-line antiretroviral treatment in resource-constrained settings.
    Lynen L; Van Griensven J; Elliott J
    Curr Opin HIV AIDS; 2010 Jan; 5(1):1-5. PubMed ID: 20046141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of two commercially available alternatives for HIV-1 viral load testing in resource-limited settings.
    Steegen K; Luchters S; De Cabooter N; Reynaerts J; Mandaliya K; Plum J; Jaoko W; Verhofstede C; Temmerman M
    J Virol Methods; 2007 Dec; 146(1-2):178-87. PubMed ID: 17686534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular-based laboratory testing and monitoring for human immunodeficiency virus infections.
    Constantine N; Zhao R
    Clin Lab Sci; 2005; 18(4):263-70. PubMed ID: 16315745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the Generic HIV Viral Load assay with the Amplicor HIV-1 monitor v1.5 and Nuclisens HIV-1 EasyQ v1.2 techniques for plasma HIV-1 RNA quantitation of non-B subtypes: the Kesho Bora preparatory study.
    Rouet F; Foulongne V; Viljoen J; Steegen K; Becquart P; Valéa D; Danaviah S; Segondy M; Verhofstede C; Van de Perre P;
    J Virol Methods; 2010 Feb; 163(2):253-7. PubMed ID: 19837114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of viral load by PCR and use of plasma preparation tubes for quantification of human immunodeficiency virus type 1.
    García-Bujalance S; Ladrón de Guevara C; González-García J; Arribas JR; Zamora F; Gutiérrez A
    J Microbiol Methods; 2007 May; 69(2):384-6. PubMed ID: 17363096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying HIV for monitoring antiretroviral therapy in resource-poor settings.
    Stevens WS; Scott LE; Crowe SM
    J Infect Dis; 2010 Apr; 201 Suppl 1():S16-26. PubMed ID: 20225942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges to pediatric HIV care and treatment in South Africa.
    Meyers T; Moultrie H; Naidoo K; Cotton M; Eley B; Sherman G
    J Infect Dis; 2007 Dec; 196 Suppl 3():S474-81. PubMed ID: 18181697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 load quantitation: a 17-year perspective.
    Holodniy M
    J Infect Dis; 2006 Sep; 194 Suppl 1():S38-44. PubMed ID: 16921471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The measurement of HIV-1 viral load in resource-limited settings: how and where?
    Rouet F; Rouzioux C
    Clin Lab; 2007; 53(3-4):135-48. PubMed ID: 17447649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children.
    Jeremy RJ; Kim S; Nozyce M; Nachman S; McIntosh K; Pelton SI; Yogev R; Wiznia A; Johnson GM; Krogstad P; Stanley K;
    Pediatrics; 2005 Feb; 115(2):380-7. PubMed ID: 15687448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new affordable flow cytometry based method to measure HIV-1 viral load.
    Greve B; Weidner J; Cassens U; Odaibo G; Olaleye D; Sibrowski W; Reichelt D; Nasdala I; Göhde W
    Cytometry A; 2009 Mar; 75(3):199-206. PubMed ID: 19034933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laboratory evaluation of the Liat HIV Quant (IQuum) whole-blood and plasma HIV-1 viral load assays for point-of-care testing in South Africa.
    Scott L; Gous N; Carmona S; Stevens W
    J Clin Microbiol; 2015 May; 53(5):1616-21. PubMed ID: 25740777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dried blood spots perform well in viral load monitoring of patients who receive antiretroviral treatment in rural Tanzania.
    Johannessen A; Garrido C; Zahonero N; Sandvik L; Naman E; Kivuyo SL; Kasubi MJ; Gundersen SG; Bruun JN; de Mendoza C
    Clin Infect Dis; 2009 Sep; 49(6):976-81. PubMed ID: 19663598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV viral load monitoring in resource-limited regions: optional or necessary?
    Calmy A; Ford N; Hirschel B; Reynolds SJ; Lynen L; Goemaere E; Garcia de la Vega F; Perrin L; Rodriguez W
    Clin Infect Dis; 2007 Jan; 44(1):128-34. PubMed ID: 17143828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.